Loading...
Loading...

Aspirin dosing, a potential new drug for SVT, apixaban in patients with ESRD, TAVR, and saunas, are discussed in this week's podcast
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
This Week in Cardiology